331 related articles for article (PubMed ID: 26295565)
1. Intralesional immunotherapy with tuberculin purified protein derivative (PPD) in recalcitrant wart: A randomized, placebo-controlled, double-blind clinical trial including an extra group of candidates for cryotherapy.
Amirnia M; Khodaeiani E; Fouladi DF; Masoudnia S
J Dermatolog Treat; 2016; 27(2):173-8. PubMed ID: 26295565
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Cryotherapy Combined With Intralesional Purified Protein Derivative (PPD) Versus Intralesional PPD Monotherapy in the Treatment of Multiple Common Warts.
Awad SM; Gomaa AS; Hassan HA; Tawfik YM
J Cutan Med Surg; 2023; 27(2):117-125. PubMed ID: 36705474
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of IL-12 serum level in patients with recalcitrant multiple common warts, treated by intralesional tuberculin antigen.
Abd-Elazeim FM; Mohammed GF; Fathy A; Mohamed RW
J Dermatolog Treat; 2014 Jun; 25(3):264-7. PubMed ID: 23336207
[TBL] [Abstract][Full Text] [Related]
4. Intralesional immunotherapy with purified protein derivative (PPD) for cryotherapy-resistant warts.
Kaimal S; Gopinath H; Premalatha V
Int J Dermatol; 2020 Jun; 59(6):726-729. PubMed ID: 32112396
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of intralesional tuberculin purified protein derivative versus cryotherapy in the treatment of warts: An assessor-blinded, randomized controlled trial.
Wan Ahmad Kammal WSL; Jamil A; Md Nor N
Dermatol Ther; 2021 Sep; 34(5):e15080. PubMed ID: 34351693
[TBL] [Abstract][Full Text] [Related]
6. Combined intralesional injection of tuberculin purified protein derivative plus cryotherapy versus each alone in the treatment of multiple common warts.
Ibrahim H; El Taieb M; Nada E; Kamal E; Hegazy E
Dermatol Ther; 2022 Apr; 35(4):e15350. PubMed ID: 35103366
[TBL] [Abstract][Full Text] [Related]
7. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study.
Shaheen MA; Salem SA; Fouad DA; El-Fatah AA
Dermatol Ther; 2015; 28(4):194-200. PubMed ID: 25847793
[TBL] [Abstract][Full Text] [Related]
8. Intralesional Measles, Mumps, Rubella Vaccine versus Tuberculin Purified Protein Derivative Injections in the Treatment of Palmoplantar and Periungual Warts: A Double-Blind Randomized Controlled Trial.
Rutnin S; Namasondhi A; Pomsoong C; Kositkuljorn C; Anuntrangsee T; Thadanipon K
Dermatology; 2023; 239(1):109-115. PubMed ID: 36282051
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy in viral warts with intradermal
Podder I; Bhattacharya S; Mishra V; Sarkar TK; Chandra S; Sil A; Pal S; Kumar D; Saha A; Shome K; Bandyopadhyay D; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(3):411. PubMed ID: 27852999
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, randomized controlled trial to compare the effectiveness and safety of purified protein derivative of tuberculin antigen with
Chandra S; Sil A; Datta A; Pal S; Das NK
Indian J Dermatol Venereol Leprol; 2019; 85(4):355-366. PubMed ID: 31172979
[TBL] [Abstract][Full Text] [Related]
11. Intralesional Purified Protein Derivative of Tuberculin Versus Intralesional Mycobacterium W Vaccine in Treatment of Recalcitrant Extragenital Warts: A Randomized, Single-Blinded, Comparative Study.
Mohta A; Jain SK; Mehta RD; Arora A
Indian J Dermatol; 2022; 67(1):26-30. PubMed ID: 35656274
[TBL] [Abstract][Full Text] [Related]
12. Intralesional immunotherapy for multiple recalcitrant plantar warts: Candida antigen is superior to intralesional purified protein derivative.
Nofal A; Adel L; Fawzy M; Elkholy BM
Dermatol Ther; 2022 Jun; 35(6):e15440. PubMed ID: 35285995
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy using purified protein derivative in the treatment of warts: An open uncontrolled trial.
Saoji V; Lade NR; Gadegone R; Bhat A
Indian J Dermatol Venereol Leprol; 2016; 82(1):42-6. PubMed ID: 26728809
[TBL] [Abstract][Full Text] [Related]
14. Intralesional injection of mumps or Candida skin test antigens: a novel immunotherapy for warts.
Johnson SM; Roberson PK; Horn TD
Arch Dermatol; 2001 Apr; 137(4):451-5. PubMed ID: 11295925
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of intralesional tuberculin protein purified derivative (PPD) and intralesional measles, mumps, rubella (MMR) vaccine for multiple resistant warts.
Mohammed YF; Ibrahim HS; Elbarbary MA; Elsaie ML
J Cosmet Dermatol; 2021 Mar; 20(3):868-874. PubMed ID: 33118675
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of single versus multiple intralesional immunotherapy with purified protein derivative (PPD) in the treatment of multiple verruca vulgaris.
Milante RR; Venida-Tablizo A; King-Ismael D
Int J Dermatol; 2019 Dec; 58(12):1477-1482. PubMed ID: 31591706
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of intralesional injection of vitamin D
Elsayed Ghaly N; El-Ashmawy AA; Abou Zeid M; E Shaker ES
J Cosmet Dermatol; 2021 Apr; 20(4):1231-1240. PubMed ID: 32892493
[TBL] [Abstract][Full Text] [Related]
18. Intralesional purified protein derivative versus zinc sulfate 2% in the treatment of pediatric warts: Clinical and dermoscopic evaluation.
Awad A; Ismael AF; Sallam M; Abdelgaber S
J Cosmet Dermatol; 2022 Oct; 21(10):4637-4645. PubMed ID: 35212136
[TBL] [Abstract][Full Text] [Related]
19. Intralesional immunotherapy for the treatment of warts: A network meta-analysis.
Salman S; Ahmed MS; Ibrahim AM; Mattar OM; El-Shirbiny H; Sarsik S; Afifi AM; Anis RM; Yakoub Agha NA; Abushouk AI
J Am Acad Dermatol; 2019 Apr; 80(4):922-930.e4. PubMed ID: 30003983
[TBL] [Abstract][Full Text] [Related]
20. Triple Intralesional Antigen Immunotherapy versus Monoantigen in the Treatment of Multiple Recalcitrant Warts.
Nofal AA; Elkholy BM; Abd-Elmonsef ER; Nofal HO
Dermatol Ther (Heidelb); 2022 May; 12(5):1225-1237. PubMed ID: 35449500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
